These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 31197578)
1. Reprogramming of Keratinocytes as Donor or Target Cells Holds Great Promise for Cell Therapy and Regenerative Medicine. Zhang Y; Hu W; Ma K; Zhang C; Fu X Stem Cell Rev Rep; 2019 Oct; 15(5):680-689. PubMed ID: 31197578 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560 [TBL] [Abstract][Full Text] [Related]
3. Direct conversion of mouse embryonic fibroblasts into functional keratinocytes through transient expression of pluripotency-related genes. Iacovides D; Rizki G; Lapathitis G; Strati K Stem Cell Res Ther; 2016 Jul; 7(1):98. PubMed ID: 27473056 [TBL] [Abstract][Full Text] [Related]
4. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Itoh M; Kiuru M; Cairo MS; Christiano AM Proc Natl Acad Sci U S A; 2011 May; 108(21):8797-802. PubMed ID: 21555586 [TBL] [Abstract][Full Text] [Related]
5. Generation of Induced Pluripotent Stem Cells from Human Epidermal Keratinocytes. Yang YH; Zhang RZ; Cheng S; Xu B; Tian T; Shi HX; Xiao L; Chen RH Cell Reprogram; 2018 Dec; 20(6):356-364. PubMed ID: 30388030 [TBL] [Abstract][Full Text] [Related]
6. Rat embryonic fibroblasts improve reprogramming of human keratinocytes into induced pluripotent stem cells. Linta L; Stockmann M; Kleinhans KN; Böckers A; Storch A; Zaehres H; Lin Q; Barbi G; Böckers TM; Kleger A; Liebau S Stem Cells Dev; 2012 Apr; 21(6):965-76. PubMed ID: 21699413 [TBL] [Abstract][Full Text] [Related]
7. Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases. Li R; Bai Y; Liu T; Wang X; Wu Q Protein Cell; 2013 Jun; 4(6):415-24. PubMed ID: 23686735 [TBL] [Abstract][Full Text] [Related]
8. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells. Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802 [TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells and their implication for regenerative medicine. Csobonyeiova M; Polak S; Koller J; Danisovic L Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593 [TBL] [Abstract][Full Text] [Related]
10. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs. Menon S; Shailendra S; Renda A; Longaker M; Quarto N Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822 [TBL] [Abstract][Full Text] [Related]
12. Generation of keratinocyte stem-like cells from human fibroblasts via a direct reprogramming approach. Zhao A; Yang Y; Pan X; Pan Y; Cai S Biotechnol Prog; 2020 May; 36(3):e2961. PubMed ID: 31930712 [TBL] [Abstract][Full Text] [Related]
13. Reprogramming human adipose tissue stem cells using epidermal keratinocyte extracts. Xie F; Tang X; Zhang Q; Deng C Mol Med Rep; 2015 Jan; 11(1):182-8. PubMed ID: 25333210 [TBL] [Abstract][Full Text] [Related]
14. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. Ghosh Z; Wilson KD; Wu Y; Hu S; Quertermous T; Wu JC PLoS One; 2010 Feb; 5(2):e8975. PubMed ID: 20126639 [TBL] [Abstract][Full Text] [Related]
15. Intermediate Standstill Clones Trapped in the Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells. Zhang L; Wang Y; Zhang Y; Wang L; Huang H Cell Reprogram; 2020 Apr; 22(2):99-105. PubMed ID: 32182120 [TBL] [Abstract][Full Text] [Related]
16. Diversity of dermal fibroblasts as major determinant of variability in cell reprogramming. Sacco AM; Belviso I; Romano V; Carfora A; Schonauer F; Nurzynska D; Montagnani S; Di Meglio F; Castaldo C J Cell Mol Med; 2019 Jun; 23(6):4256-4268. PubMed ID: 30980516 [TBL] [Abstract][Full Text] [Related]
18. Comparing the reprogramming efficiency of mouse embryonic fibroblasts, mouse bone marrow mesenchymal stem cells and bone marrow mononuclear cells to iPSCs. Wang L; Zhu M; Guo Q; Fan X; Lu Y; Zhu S; Wang Y; Huang Y; Wang Z In Vitro Cell Dev Biol Anim; 2012 Apr; 48(4):236-43. PubMed ID: 22457082 [TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine. Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380 [TBL] [Abstract][Full Text] [Related]
20. Overcoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and quality. Cao S; Loh K; Pei Y; Zhang W; Han J Protein Cell; 2012 Nov; 3(11):834-45. PubMed ID: 23073833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]